Barclays’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,100
Closed -$81K 7059
2019
Q1
$81K Hold
1,100
﹤0.01% 5526
2018
Q4
$66K Buy
+1,100
New +$88.7K ﹤0.01% 5304
2018
Q1
Sell
-17,500
Closed -$817K 7168
2017
Q4
$817K Hold
17,500
﹤0.01% 3316
2017
Q3
$885K Sell
17,500
-20,900
-54% -$973K ﹤0.01% 3112
2017
Q2
$1.91M Buy
38,400
+13,400
+54% +$627K ﹤0.01% 2288
2017
Q1
$1.06M Buy
+25,000
New +$1.11M ﹤0.01% 2678

Other funds holding HQY

Barclays's HQY Position: Q1 2026 in Review

Barclays reduced its HealthEquity (HQY) stake by 73% in Q1 2026, selling an estimated $11.1M and leaving 50,122 shares worth $4.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1928.

Barclays first reported a position in HQY in Q4 2014 and has held it in 44 quarters since. The position peaked at $21M in Q2 2025. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.

  • Barclays held 50,122 shares of HealthEquity worth $4.19M as of Q1 2026.
  • Barclays sold 134,982 HealthEquity shares in Q1 2026, an estimated $11.1M.
  • HealthEquity made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1928 holding.
  • Barclays first reported a position in HealthEquity in Q4 2014 and has held it in 44 quarters since.
  • Barclays's HealthEquity position peaked at $21M in Q2 2025.
  • 485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.